Adding carboplatin to presurgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer

Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy

Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer

Radiotherapy access in low and middle income countries

The work of the Global Academic Program in Africa

ASH 2015: Latest in CLL

The impact of microbiota on the immune response

High dose chemotherapy plus transplant remains standard care for young newly diagnosed multiple myeloma patients

ASH 2015: Highlights in mantle cell lymphoma

Incidence of and predictors for early death in paediatric patients with acute promyelocytic leukaemia

Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia